Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01417195 · ClinicalTrials.gov registry record · Phase 4
Menopur Mixed Protocol
A Phase 4 study of Infertility, sponsored by Ferring Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 122
- Enrollment target
- 10
- Study locations
NCT01417195: Completed Phase 4 study of Infertility, sponsored by Ferring Pharmaceuticals.
NCT01417195 is a Phase 4 study of Infertility that has completed, run by Ferring Pharmaceuticals. The registered enrollment target is 122 participants, below the 7,588-participant average among 74 other Infertility trials with a reported enrollment target (98% lower). The trial reports 10 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01417195, a Phase 4 study of Infertility, has completed, sponsored by Ferring Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 122 participants
- Enrollment target
- 10
- Study locations
Study Summary
The objective of this study was to compare the fertilization rate between the combination of Menopur and Bravelle mixed in the same syringe and Menopur alone, both administered subcutaneously (SC), in subjects undergoing Assisted Reproductive Technology (ART). Additionally the study assessed subjects' ability to mix and store the combination of Menopur and Bravelle and to assess safety of the Menopur and Bravelle combination.
Primary Outcome
The fertilization rate was defined for each participant and calculated as the number of 2 pronuclei (fertilized) (2PN) oocytes divided by the total number of oocytes retrieved multiplied by 100.
Conditions Studied
Interventions
- DRUG Bravelle
- DRUG Menopur
Study Locations (10)
Texas
- The Center for Assisted Reproduction - Bedford
- Houston Fertility Institute - Houston
- Center of Reproductive Medicine - Webster
Illinois
- Fertility Center of Illinois - Chicago
- The Advanced IVF Institute - Naperville
Colorado
- Colorado Center for Reproductive Medicine - Lone Tree
Florida
- Women's Medical Research Group - Clearwater
Georgia
- Reproductive Biology Associates - Atlanta
Maryland
- Shady Grove Fertility - Rockville
Washington
- Seattle Reproductive Medicine - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-01 |
| Phase | Phase 4 |
What the finished NCT01417195 record still lists
NCT01417195 is an interventional study that assigns participants to a tested intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap, below the 7,588-participant average among 74 other Infertility trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 2 interventions - of which Bravelle is the first listed.
NCT01417195 lists 10 locations in 7 states (Texas, Illinois, Colorado).
Frequently Asked Questions
What is clinical trial NCT01417195 about?
NCT01417195 is a clinical study titled "Menopur Mixed Protocol". The objective of this study was to compare the fertilization rate between the combination of Menopur and Bravelle mixed in the same syringe and Menopur alone, both administered subcutaneously (SC), in subjects undergoing Assisted Reproductive Technology (ART). Additionally the study assessed subject...
What is the current status of trial NCT01417195?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 122 participants. The study started on 2011-07. Estimated completion is 2012-01.
What conditions does trial NCT01417195 study?
This clinical trial studies the following conditions: Infertility.
What interventions are being tested in trial NCT01417195?
The interventions under investigation include: Bravelle (DRUG), Menopur (DRUG).
Who is sponsoring clinical trial NCT01417195?
This trial is sponsored by Ferring Pharmaceuticals, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01417195 being conducted?
This trial has 10 study locations across Colorado, Florida, Georgia, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01417195's enrollment target sits among peer trials
122 52nd of 74 higher than 23 of 74 other Infertility trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
GnRH for Luteal Support in IVF/ICSI/FET Cycles
RECRUITING · Phase 4
-
Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation
ACTIVE NOT RECRUITING · Phase 4
-
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
COMPLETED · Phase 4
-
Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer
COMPLETED · Phase 4
-
Concomitant Administration of FSH With HCG Improves Oocyte Maturation and Quality Double -Blinded Randomized Trial
COMPLETED · Phase 4
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03363373 · 122 participants · Phase 2
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
- NCT03463954 · 122 participants · NA
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
- NCT04503265 · 122 participants · Phase 1
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
- NCT04700527 · 122 participants · Phase 1
The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia